China Health Group Inc. (8225.HK) HKSE
0.11
-0.013(-10.48%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 130.53M |
| Enterprise Value | 107.09M |
| P/E Ratio | -4.01 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 3.14 |
| Price/Book Ratio | 1.85 |
| Enterprise/Revenue | 2.42 |
| Enterprise/EBITDA | -35.28 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.78 |
| Operating Margin | -0.31 |
Management Effectiveness
| Return On Assets | -0.29 |
| Return On Equity | -0.36 |
Income Statement
| Revenue | 27.82M |
| Revenue/Share | 0.03 |
| Gross Profit | 15.97M |
| EBITDA | -14.05M |
| Net Income | -14.57M |
| Diluted EPS | -0.01 |
Balance Sheet
| Total Cash | 25.16M |
| Total Cash/Share | 0.03 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.17 |
| Book Value Per Share | 0.05 |
Price History
| 52-Week Change | -26.09 |
| 52-Week High | 0.2 |
| 52-Week Low | 0.12 |
| Moving Average 50 Days | 0.13 |
| Moving Average 200 Days | 0.15 |
Statistics
| Average Volume | 57,333 |
| Shares Outstanding | 995.35M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 747:500 |
| Last Split Date | October 13, 2014 |
